Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…

Background Washington State served as the initial epicenter of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic in the United States. An understanding of …

Increased diagnostics are urgently needed to contain the spread of coronavirus disease
2019 (COVID-19). Home self-collected swabs may increase testing access while minimizing …

BACKGROUND SARS-CoV-2–specific antibodies may protect from reinfection and disease,
providing rationale for administration of plasma containing SARS-CoV-2–neutralizing …

Homo sapiens harbor two distinct, medically significant species of simplexviruses, herpes
simplex virus (HSV)-1 and HSV-2, with estimated divergence 6–8 million years ago (MYA). …

The COVID-19 epidemic of 2019–20 is due to the novel coronavirus SARS-CoV-2. Following
first case description in December, 2019 this virus has infected over 10 million individuals …

Incurable chronic viral infections are a major cause of morbidity and mortality worldwide.
One potential approach to cure persistent viral infections is via the use of targeted …

In March 1963, President John F. Kennedy told the American people that he was haunted by
the prospect of ‘15 or 20’nuclear powers by 1975. 1 Come that year, in a world with still only …

Measuring the adaptive immune response to SARS-CoV-2 can enable the assessment of
past infection as well as protective immunity and the risk of reinfection. While neutralizing …

Background Orolabial herpes simplex virus type 1 (HSV-1) infection has a wide spectrum of
severity in immunocompetent persons. To study the role of viral genotype and host immunity, …